Researchers from Karolinska Institute have come up with a new drug that can potentially extend survival in patients with inoperable pancreatic cancer.
A new drug that can potentially extend survival in patients with inoperable pancreatic cancer has been developed by researchers from the Karolinska Institute.
The research team led by Prof. Matthias Lohr have found that a new drug paclitaxel in combination with weekly infusions of gemcitabine could destroy new blood vessels that grow around tumours.
Pancreatic Cancer - All About the Disease, its Diagnosis and Management
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
Pancreatic cancer often involves its exocrine part. It grows aggressively, and often detected late. Treatment options include surgery, radiation and chemotherapy.
"EndoTAG consists of charged particles that bind preferentially to the fast-growing endothelial cells in new blood vessels being formed by tumours," said Lohr.
"The drug, paclitaxel, is then released and thus directly reaches an important target in tumours, i.e. the vessels. Paclitaxel itself is not very efficient in pancreratic cancer," Lohr added.
Exercise of Any Sort can Help Keep Cancer at Bay
Walking, playing sport, going to the gym or even housework can help keep cancer at bay, according to a new study.
Walking, playing sport, going to the gym or even housework can help keep cancer at bay, according to a new study.
Patients given gemcitabine alone survived on average 7.2 months, compared to up to 13.6 months for patients who received repeated doses of the combination (EndoTAG plus gemcitabine).
Advertisement
Pavarotti to Stay in Hospital and Undergo More Cancer Tests
Opera singer Luciano Pavarotti will have to stay in hospital for some more time, as more tests are to be conducted on him in relation to his pancreatic cancer.
Opera singer Luciano Pavarotti will have to stay in hospital for some more time, as more tests are to be conducted on him in relation to his pancreatic cancer.
The study was presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm.
Advertisement
Study Identify Protein That Helps Pancreatic Cancer Cells Evade Immune System
Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia, have found that a protein that helps pancreatic cancer cells evade the immune system.
Researchers at Jefferson’s Kimmel Cancer Center in Philadelphia, have found that a protein that helps pancreatic cancer cells evade the immune system.
RAS/SK
